Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
Independent pricing analysis of Mark Cuban Cost Plus Drug Company. We break down the 15% markup model, compare costs to GoodRx, insurance copays, and Medicare Part D, and assess whether the savings hold up across common medications.
Read clinical reviewAn independent clinical review of Cost Plus Drugs' safety record, regulatory compliance, pharmacy licensing, and how its low-margin generic model compares to alternatives.
Read clinical reviewAn evidence-based comparison of Cost Plus Drugs against GoodRx, RxSaver, Amazon Pharmacy, Honeybee Health, and other low-cost pharmacy alternatives for generics, specialty drugs, and telehealth prescriptions.
Read clinical reviewAn evidence-based analysis of Mark Cuban Cost Plus Drug Company's clinical limitations, including formulary gaps, lack of clinical oversight, and what patients should know before switching from traditional pharmacy benefits.
Read clinical review